Google
AVR — ANTERIS TECHNOLOGIES GLOBAL CORP. COMMON STOCK (Healthcare >> Medical Instruments & Supplies)
AVR FAQ
What is AVR's ROE?
ANTERIS TECHNOLOGIES GLOBAL CORP. COMMON STOCK reports a Return on Equity (ROE) of -34.23%.
What is AVR's dividend yield?
ANTERIS TECHNOLOGIES GLOBAL CORP. COMMON STOCK offers a dividend yield of 0.00%.
What is AVR's Deepscope Quality Score?
Deepscope rates AVR's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy AVR?
Deepscope's AI Timing Score for AVR is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does AVR belong to?
ANTERIS TECHNOLOGIES GLOBAL CORP. COMMON STOCK is classified under the Healthcare >> Medical Instruments & Supplies sector on the NASDAQ exchange.
|
USD 9.64
Price
-0.01
(-0.10%)
Day Change
|
|
|---|
AVR, the overall quality is not good ( Quality = 38) but the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Growth of ROA was below our criteria in the last year.
Net profit margin is relatively low.
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Quality Factors |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 98 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 9.64 |
| PBV / Sector |
3.13 / 4.41
|
| Earning Per Share | -1.05 |
| PE / Sector |
N/A / 36.90
|
| PEG or PE/Growth / Sector |
N/A / -0.97
|
| Average 1M Daily Value |
11.14 M
GREAT
|
| Average 1W Daily Value |
14.12 M
GREAT
|
| Timing Factors |
|
85% |
| Financial Health |
|
41% |
| Ability to Make Profit |
|
52% |
| Return to Investors |
|
8% |
| Registration Details |
| Analyze Date | 2026-06-06 09:09:30 |
| Symbol | AVR |
| Name | ANTERIS TECHNOLOGIES GLOBAL CORP. COMMON STOCK |
| Sector | Healthcare >> Medical Instruments & Supplies |
| Market | NASDAQ |
| Listed Shares | 97.34 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 871.21 / 16,249.68 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: Toowong Tower, Toowong, QLD, Australia, 4066
Phone: 61 7 3152 3200
Website: https://anteristech.com
Employees: 174
Description: Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.
ME vs SECTOR Healthcare >> Medical Instruments & Supplies
Click a bubble to view stock details · Bubble size represents market capitalization share
